Trending...
- Talaria E-bike China Source Cuts Talaria Sting MX5 Pro Pricing by $700 - 180
- Long Beach to Launch Time Capsule Honoring America's 250th Anniversary as Part of 908 Day Celebration
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that senior management is scheduled to present at the following investor conferences:
Event: Wells Fargo Healthcare Conference
Date: Thursday, September 8, 2022
Time: 10:25 a.m. Eastern Time
Event: Morgan Stanley Healthcare Conference
Date: Monday, September 12, 2022
Time: 11:05 a.m. Eastern Time
Interested parties may access a live and archived webcast of each presentation by visiting the Axonics investor relations website.
More on The Californer
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
More on The Californer
Axonics sacral neuromodulation (SNM) systems provide patients suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company's best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
Contacts
Neil Bhalodkar
949-336-5293
ir@axonics.com
Event: Wells Fargo Healthcare Conference
Date: Thursday, September 8, 2022
Time: 10:25 a.m. Eastern Time
Event: Morgan Stanley Healthcare Conference
Date: Monday, September 12, 2022
Time: 11:05 a.m. Eastern Time
Interested parties may access a live and archived webcast of each presentation by visiting the Axonics investor relations website.
More on The Californer
- Ready is how California leads, and every Californian has a role to play
- Stockdale Capital Partners and Hamilton Lane Acquire So Cal Shopping Center for $157 Mil
- New Video Guide Reveals How Seniors Can Explore San Francisco on a Budget With Discounts & Fre
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
More on The Californer
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
- TitleChain Foundation Publishes Model Legislation Guaranteeing Free Public Access to Open-Weight AI
- Connect Names Austin Robertson Marketing & Events Coordinator
- Countrywide Rental Delivers Efficient Waste Management Solutions to Burnwell, Alabama Job Sites
- SCAMS - The Most Dangerous Scams Perpetrated in the USA
Axonics sacral neuromodulation (SNM) systems provide patients suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company's best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
Contacts
Neil Bhalodkar
949-336-5293
ir@axonics.com
Filed Under: Business
0 Comments
Latest on The Californer
- Responsive Web Designs Services in San Diego Drive Digital Growth
- California: On September 11, Governor Newsom welcomes CAL FIRE's newest leaders as they answer the call to serve
- Kindness Village to Build a New Model for Attainable Housing
- The Best Policy Administration System for Small-to-Mid Size Insurers & MGAs
- California: Governor Newsom proclaims Patriot Day
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- City of Long Beach Extends Heat Alert, Advises Residents to Take Precautions Against Heat
- iDAREcares and Majapahit Martial Arts Bring Silat & Kali to Indonesian Celebration in Los Angeles
- Emmy Nominee Sepideh Moafi And Peabody Award Winner Aasif Mandvi To Receive Cultural Impact Awards
- Anglepoint Named to Fast Company's 2026 Best Workplaces for Innovators List
- Wavymy New-In Glueless Wig: Blowout Wave 7x5 Glueless Bob Wig
- Gateway Oaks Dental Marks 18th Year in Sacramento by Investing in Modern Dental Technology
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- AI Biological Weapon Concerns Increase Focus on CBRN Protection for Private Shelters
- Designer-Inspired Jewellery Gifts: Timeless Pieces for Every Occasion
- Build a Stronger Online Presence with Strategic Web Design & Development
- California: What they are saying: National leaders and lawmakers celebrate Governor Newsom's signature on landmark child safety chatbot and social media laws
- California: Governor Newsom announces appointments 9.10.26
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany